161 related articles for article (PubMed ID: 23542715)
1. Benign atypical intravascular CD30(+) T-cell proliferation: a reactive condition mimicking intravascular lymphoma.
Riveiro-Falkenbach E; Fernández-Figueras MT; Rodríguez-Peralto JL
Am J Dermatopathol; 2013 Apr; 35(2):143-50. PubMed ID: 23542715
[TBL] [Abstract][Full Text] [Related]
2. Benign atypical intravascular CD30+ T-cell proliferation: a recently described reactive lymphoproliferative process and simulator of intravascular lymphoma: report of a case associated with lichen sclerosus and review of the literature.
Kempf W; Keller K; John H; Dommann-Scherrer C
Am J Clin Pathol; 2014 Nov; 142(5):694-9. PubMed ID: 25319987
[TBL] [Abstract][Full Text] [Related]
3. CD30+ lymphoproliferative disorders: histopathology, differential diagnosis, new variants, and simulators.
Kempf W
J Cutan Pathol; 2006 Feb; 33 Suppl 1():58-70. PubMed ID: 16412214
[TBL] [Abstract][Full Text] [Related]
4. MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.
Kempf W; Kutzner H; Cozzio A; Sander CA; Pfaltz MC; Müller B; Pfaltz M
Br J Dermatol; 2008 Jun; 158(6):1280-7. PubMed ID: 18410414
[TBL] [Abstract][Full Text] [Related]
5. Characterization of primary cutaneous CD8+/CD30+ lymphoproliferative disorders.
Martires KJ; Ra S; Abdulla F; Cassarino DS
Am J Dermatopathol; 2015 Nov; 37(11):822-33. PubMed ID: 26485239
[TBL] [Abstract][Full Text] [Related]
6. CD30(+) cutaneous lymphoproliferative disorders with pseudocarcinomatous hyperplasia are associated with a T-helper-17 cytokine profile and infiltrating granulocytes.
Guitart J; Martinez-Escala ME; Deonizio JM; Gerami P; Kadin ME
J Am Acad Dermatol; 2015 Mar; 72(3):508-15. PubMed ID: 25582534
[TBL] [Abstract][Full Text] [Related]
7. Atypical intravascular CD30+ T-cell proliferation following trauma in a healthy 17-year-old male: first reported case of a potential diagnostic pitfall and literature review.
Baum CL; Stone MS; Liu V
J Cutan Pathol; 2009 Mar; 36(3):350-4. PubMed ID: 19220631
[TBL] [Abstract][Full Text] [Related]
8. Large CD30-positive cells in benign, atypical lymphoid infiltrates of the skin.
Werner B; Massone C; Kerl H; Cerroni L
J Cutan Pathol; 2008 Dec; 35(12):1100-7. PubMed ID: 18616762
[TBL] [Abstract][Full Text] [Related]
9. A case of CD30+ nasal natural killer/T-cell lymphoma.
Ferenczi K; Summers P; Aubert P; Cooper B; Meyerson H; Cooper KD; Honda K
Am J Dermatopathol; 2008 Dec; 30(6):567-71. PubMed ID: 19033930
[TBL] [Abstract][Full Text] [Related]
10. A rare case of intravascular large T-cell lymphoma with an unusual T helper phenotype.
Deetz CO; Gilbertson KG; Anadkat MJ; Dehner LP; Lu D
Am J Dermatopathol; 2011 Dec; 33(8):e99-102. PubMed ID: 22024573
[TBL] [Abstract][Full Text] [Related]
11. Nodal Involvement by CD30
Lezama LS; Gratzinger D
Arch Pathol Lab Med; 2018 Jan; 142(1):139-142. PubMed ID: 29257929
[TBL] [Abstract][Full Text] [Related]
12. Pityriasis lichenoides et varioliformis acuta with numerous CD30(+) cells: a variant mimicking lymphomatoid papulosis and other cutaneous lymphomas. A clinicopathologic, immunohistochemical, and molecular biological study of 13 cases.
Kempf W; Kazakov DV; Palmedo G; Fraitag S; Schaerer L; Kutzner H
Am J Surg Pathol; 2012 Jul; 36(7):1021-9. PubMed ID: 22472952
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the tumor microenvironment in primary cutaneous CD30-positive lymphoproliferative disorders: a predominance of CD163-positive M2 macrophages.
De Souza A; Tinguely M; Burghart DR; Berisha A; Mertz KD; Kempf W
J Cutan Pathol; 2016 Jul; 43(7):579-88. PubMed ID: 27080437
[TBL] [Abstract][Full Text] [Related]
14. CD30+ lymphoproliferative disorders of the skin: still an open question.
Alaibac M; Zarian H; Russo I; Peserico A
G Ital Dermatol Venereol; 2012 Dec; 147(6):545-52. PubMed ID: 23149700
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous CD30-positive lymphoproliferative disorders with CD8 expression: a clinicopathologic study of 21 cases.
Plaza JA; Feldman AL; Magro C
J Cutan Pathol; 2013 Feb; 40(2):236-47. PubMed ID: 23189966
[TBL] [Abstract][Full Text] [Related]
16. [Analyses of the rearrangement of T-cell receptor- and immunoglobulin genes in the diagnosis of lymphoproliferative disorders].
Griesser DH
Veroff Pathol; 1995; 144():1-109. PubMed ID: 7856305
[TBL] [Abstract][Full Text] [Related]
17. Primary cutaneous CD30+ lymphoproliferative disorder--a 10-year follow-up. A case report and differential diagnosis.
Szpor J; Dyduch G; Gałazka K; Bahyrycz J; Stój A; Tomaszewska R
Pol J Pathol; 2009; 60(1):43-8. PubMed ID: 19670703
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders.
Benner MF; Jansen PM; Meijer CJ; Willemze R
Br J Dermatol; 2009 Jul; 161(1):121-7. PubMed ID: 19416236
[TBL] [Abstract][Full Text] [Related]
19. Intralymphatic CD30+ T-cell proliferation during DRESS: a mimic of intravascular lymphoma.
Weingertner N; Mitcov M; Chenard MP; Cribier B
J Cutan Pathol; 2016 Nov; 43(11):1036-1040. PubMed ID: 27433889
[TBL] [Abstract][Full Text] [Related]
20. Primary cutaneous CD30+ anaplastic large cell lymphoma in a heart transplant patient: case report and literature review.
Belloni-Fortina A; Montesco MC; Piaserico S; Bordignon M; Tona F; Feltrin G; Alaibac M
Acta Derm Venereol; 2009; 89(1):74-7. PubMed ID: 19197546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]